News | Coronavirus (COVID-19) | December 21, 2020

RSNA Announces Publication of First MIDRC-RICORD COVID-19 Data Set

The Radiological Society of North America (RSNA) and the RSNA COVID-19 AI Task Force announced that the first annotated data set from the RSNA International COVID-19 Open Radiology Database (RICORD) has been published by The Cancer Imaging Archive (TCIA).

Getty Images

December 21, 2020 — The Radiological Society of North America (RSNA) and the RSNA COVID-19 AI Task Force announced that the first annotated data set from the RSNA International COVID-19 Open Radiology Database (RICORD) has been published by The Cancer Imaging Archive (TCIA).

The COVID-19 pandemic is a global public health crisis. Although prediction models for COVID-19 imaging have been developed to support medical decision making, the lack of a diverse annotated data set has hindered the capabilities of these models. RSNA launched RICORD in mid-2020 with the goal of building the largest open database of anonymized COVID-19 medical images in the world. It is being made freely available to the global research and education communities to gain new insights, apply new tools such as artificial intelligence and deep learning, and accelerate clinical recognition of this novel disease.

Created through a collaboration between RSNA and the Society of Thoracic Radiology, the initial group consists of 120 COVID-19 positive chest CT images from four international sites.

“RSNA was able to draw on relationships established from prior machine learning challenges to quickly put together a COVID-19 AI Task Force,” said Carol Wu, M.D., a radiologist at MD Anderson Cancer Center and a member of the RSNA task force. “Contributing sites, already proficient at sharing data with RSNA, were able to quickly process necessary legal agreements, identify suitable cases, perform image de-identification and transfer the images in record speed.”

The image data was then annotated with detailed segmentation and classification labels. The label schema is based on guidelines outlined in the “Radiological Society of North America Expert Consensus Document on Reporting Chest CT Findings Related to COVID-19: Endorsed by the Society of Thoracic Radiology, the American College of Radiology, and RSNA” published in Radiology. Two teams of radiologists led by Scott Simpson, D.O., of the University of Pennsylvania, and Emily Tsai, M.D., of Stanford University, completed the painstaking and invaluable annotation project.

This data set represents the first published component of RICORD, and RSNA’s first contribution to the Medical Imaging and Data Resource Center (MIDRC), a consortium for rapid and flexible collection, artificial intelligence analysis and dissemination of imaging and associated data. Jointly developed by RSNA, the American College of Radiology and the American Association of Physicists in Medicine, MIDRC is funded by the National Institute of Biomedical Imaging and Bioengineering and hosted by the University of Chicago.

“RSNA is extremely proud to be part of the MIDRC effort,” said Curtis Langlotz, M.D., Ph.D., RSNA Board liaison for information technology and annual meeting. “It will build a valuable repository of data for research to address the current pandemic and will serve as a model for how to collect and aggregate data to support imaging research.”

TCIA is a service provided by the National Cancer Institute (NCI) to the cancer imaging research community that de-identifies and hosts a large archive of medical images of cancer accessible for public download.

In recognition of the urgent need for access to COVID-19 related imaging data sets for research, NCI is dedicating a portion of TCIA resources to curate and host free and open access to imaging data from patients with COVID-19. RSNA partnered with TCIA to leverage the infrastructure and processes it has in place to make these data publicly available. These data will also be incorporated into MIDRC when its data platform is fully in place in early 2021.

Radiologists have played a pivotal role in managing the pandemic, particularly when other testing methods are unavailable or when clinicians seek imaging data to inform treatment decisions. The RSNA COVID-19 AI Task Force hopes that RICORD will serve as a definitive source for COVID-19 imaging data by combining the contributions and experiences of medical imaging specialists and radiology departments worldwide.

The RICORD data collection pathway enables radiology organizations to contribute data to RICORD safely and conveniently. It provides sites with guidance for data sharing and serves to standardize exam parameters, disease annotation terminology and clinical variables across these global efforts. Importantly, it connects to sustainable storage infrastructure via the U.S. National Institutes of Health.

The RSNA COVID-19 AI Task Force will continue to update and expand both the volume and variety of data available in RICORD. A collection of COVID-19 negative chest CT control cases is in the pipeline for publication soon, along with a labeled set of 1,000 COVID-19 positive chest X-rays. An even larger set of CT and X-ray images has been submitted to RICORD and is currently being processed.

Sites interested in learning more or contributing data should visit the RICORD resources page.

From early on, RSNA has been a global leader in disseminating information and the latest research on COVID-19 through its scientific journals, webinars, podcasts and guidance documents. Additional RSNA COVID-19 resources may be found at RSNA.org/COVID-19.

Related COVID Radiology Content:

Lung Ultrasounds Could Help Determine COVID-19 Outcome

Johns Hopkins Medicine Expert Weighs Devastating Impact of COVID-19 on Healthcare Workers

CT in a Box Helps Rapidly Boost Imaging Capability at COVID Surge Hospitals

Philips Patient Management Solution keeps patients safe and personalizes care during COVID-19 at leading U.S. medical centers

CT Imaging of the 2019 Novel Coronavirus (2019-nCoV) Pneumonia

Infervision in the Frontlines Against the Coronavirus

CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV)

The Cardiac Implications of Coronavirus

VIDEO: COVID-19 Pneumonia Chest CT Scan Scroll Through

CT Imaging of the 2019 Novel Coronavirus (2019-nCoV) Pneumonia

Chest CT Can Distinguish Negative From Positive Lab Results for COVID-19

VIDEO: CT Sees Increased Use During COVID-19

Radiologists Urge Use of Medical Imaging and AI-Powered Solutions to Manage COVID-19

Stroke Scans Could Reveal COVID-19 Infection

Handheld Ultrasound Used to Monitor COVID-19 Patients With Cardiac Complications

Study Looks at CT Findings of COVID-19 Through Recovery

Using Lung X-rays to Diagnose COVID-19

How COVID-19 Affects the Brain in Neuroimaging

VIDEO: Lingering Myocardial Involvement After COVID-19 Infection — Interview with Aaron Baggish, M.D.

COVID-19 Can Impact Hearts in Young Children

VIDEO: What Are The Long-term Cardiac Impacts of COVID-19 Infection — Interview with Todd Hurst, M.D.

Find more related clinical content Coronavirus (COVID-19)

Related Content

Myocarditis among recovering COVID-19 athletes less common than previously reported

Getty Images

News | Cardiac Imaging | January 11, 2021
January 11, 2021 — In a letter published in the December issue of the American Heart Association's...
Jeff Elias, MD, is a neurosurgeon at UVA Health and a pioneer in the field of focused ultrasound.

Jeff Elias, MD, is a neurosurgeon at UVA Health and a pioneer in the field of focused ultrasound. Image courtesy of UVA Health

News | Focused Ultrasound Therapy | January 08, 2021
January 8, 2021 — A scalpel-free alternative to brain surgery has the potential to benefit people with...
The FDA is monitoring the potential impact of viral mutations, including an emerging variant from the United Kingdom known as the B.1.1.7 variant, on authorized SARS-CoV-2 molecular tests

Getty Images

News | Coronavirus (COVID-19) | January 08, 2021
January 8, 2021 — The U.S.
World-first techniques for predicting breast cancer risk from mammograms that were developed in Melbourne could revolutionise breast screening by allowing it to be tailored to women at minimal extra cost

Getty Images

News | Mammography | January 06, 2021
January 6, 2021 — World-first techniques for predicting breast cancer risk from...
Transaction accelerates Hologic’s entry into oncology growth market, provides new lab capabilities

Getty Images

News | Breast Imaging | January 06, 2021
January 6, 2021 — Hologic, Inc., a global leader in women's...
In this roundtable discussion hosted by ITN Editorial Director Melinda Taschetta-Millane, three medical experts will discuss the impact COVID-19 had on the industry in 2020, as well as projections for the industry in 2021.
Webinar | Coronavirus (COVID-19) | January 06, 2021
2020 was an unprecedented year, as the world grappled with a...
OptumInsight and Change Healthcare combine to advance a more modern, information and technology-enabled healthcare platform

Getty Images

News | Information Technology | January 06, 2021
January 6, 2020 — Optum, a diversified health services company and
Who should get the COVID vaccine? Roberto Lang, M.D., director of noninvasive cardiac imaging, University of Chicago Medical Center and former American Society of Echocardiography (ASE) president, received his first dose of the COVID vaccine in December. In addition to front line hospital workers, nursing home staff and residents also qualified for the first round of vaccinations. Right, Shannon Yaw, a nurse at a hard-hit nursing home in Michigan, received her first dose just before Christmas.

Roberto Lang, M.D., director of noninvasive cardiac imaging, University of Chicago Medical Center and former American Society of Echocardiography (ASE) president, received his first dose of the COVID vaccine in December. In addition to front line hospital workers, nursing home staff and residents also qualified for the first round of vaccinations. Right, Shannon Yaw, OTR/L, director of rehabilitation at a hard-hit nursing home in Michigan, received her first dose just before Christmas. nurse at a hard-hit nursing home in Michigan, received her first dose just before Christmas.

News | Coronavirus (COVID-19) | January 04, 2021
The Centers for Disease Control and Prevention (CDC) Dec.
Smart Breast Corporation (SmartBreast), a privately held company focused on breast cancer screening and detection, announced today that it has acquired certain molecular breast imaging (MBI) assets from Dilon Technologies, Inc. (Dilon) for an undisclosed amount.
News | Breast Imaging | January 04, 2021
January 4, 2021 — Smart Breast Corporation (SmartBreast), a privately held company focused on...
#coronavirus #COVID19 #pandemic

Getty Images

News | Radiology Imaging | January 01, 2021
The Imaging Technology News (ITN) team wishes you a Happy and Healthy New Year!